MedTrace Logo

Angiotensin Receptor Blockers in Aortic Stenosis

NCT04913870 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2024-12-20

No results posted yet for this study

Summary

This study is intended to investigate the effect of angiotensin receptor blockers (ARBs) on mild-to-moderate aortic stenosis.

Conditions

  • Aortic Stenosis
  • Aortic Valve Stenosis

Interventions

DRUG

Angiotensin Receptor Blockers

Angiotensin Receptor Blockers treatment for 2 years.

OTHER

Placebo

Placebo administration for 2 years.

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER

  • Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

    lead OTHER

Principal Investigators

  • Marie-Annick Clavel, PhD · Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • Canada
  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04913870 on ClinicalTrials.gov